Tianshui Zhongxing Bio-technology Co

Tianshui Zhongxing Bio-technology Co ROCE

The Return on Capital Employed (ROCE) of Tianshui Zhongxing Bio-technology Co (002772.SZ) as of Nov 5, 2026 is 8.99 %. In the previous year, Return on Capital Employed (ROCE) was 3.77 % — a change of 138.16% (higher).

ROCE

8.99 %

YoY

138.16%

Last updated:

In 2025, Tianshui Zhongxing Bio-technology Co's return on capital employed (ROCE) was 8.99 %, a 138.16% increase from the 3.77 % ROCE in the previous year.

The Tianshui Zhongxing Bio-technology Co ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2018
4.33 CNY
Jan 1, 2019
2.83 CNY
Jan 1, 2020
7.01 CNY
Jan 1, 2021
2.56 CNY
Jan 1, 2022
4.91 CNY
Jan 1, 2023
4.63 CNY
Jan 1, 2024
3.77 CNY
Jan 1, 2025
8.99 CNY
The Tianshui Zhongxing Bio-technology Co ROCE history
YEARROCEYoY
8.99 %+138.16%
3.77 %-18.44%
4.63 %-5.79%
4.91 %+91.49%
2.56 %-63.42%
7.01 %+147.47%
2.83 %-34.55%
4.33 %-17.79%
5.26 %-21.16%
6.68 %-33.63%
10.06 %-40.46%
16.90 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Tianshui Zhongxing Bio-technology Co Stock analysis

What does Tianshui Zhongxing Bio-technology Co do? Tianshui Zhongxing Bio-Technology Co., Ltd. generates revenue through the research, development, and manufacturing of edible and medical mushrooms. The company sells enoki mushroom, king oyster mushroom, and beech mushroom as its primary edible mushroom products. Through its subsidiaries, it also produces and sells medicinal mushroom, auxiliary materials, and agricultural by-products. The firm focuses on microbial technology, biological engineering, and new agricultural technologies for application and promotion. Its customer segments include consumers seeking edible and medicinal mushroom products, as well as businesses requiring agricultural technology solutions. The company's product portfolio includes edible mushrooms like enoki, king oyster, and beech varieties, alongside medicinal mushrooms and auxiliary materials. Subsidiaries handle production and distribution of these items, leveraging microbial and biological engineering technologies. The business targets both retail consumers and B2B clients in the agricultural and health sectors. Revenue streams are derived from direct sales of mushroom products and technology applications. Tianshui Zhongxing's operations are centered around edible and medical mushroom production, with subsidiaries expanding into agricultural by-products and technology services. The firm's revenue comes from selling enoki, king oyster, and beech mushrooms, medicinal mushrooms, and auxiliary materials. It serves markets requiring mushroom-based health products and agricultural technology innovations, with no mention of external partnerships or additional revenue sources. Tianshui Zhongxing Bio-technology Co is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Tianshui Zhongxing Bio-technology Co's Return on Capital Employed (ROCE)

Tianshui Zhongxing Bio-technology Co's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Tianshui Zhongxing Bio-technology Co's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Tianshui Zhongxing Bio-technology Co's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Tianshui Zhongxing Bio-technology Co’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Tianshui Zhongxing Bio-technology Co stock

Return on Capital Employed (ROCE) of Tianshui Zhongxing Bio-technology Co is 8.99 % in 2025.

Return on Capital Employed (ROCE) of Tianshui Zhongxing Bio-technology Co changed from 3.77 % to 8.99 %, representing a 138.16% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Tianshui Zhongxing Bio-technology Co since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Tianshui Zhongxing Bio-technology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Tianshui Zhongxing Bio-technology Co

All Key Metrics — Tianshui Zhongxing Bio-technology Co